Cisplatin + Capecitabine

Indication

Chemotherapy for locally advanced unresectable and metastatic cancer

• Cisplatin 80 mg/m2 iv over 3 hrs d1
• Capecitabine (Xeloda) 1000 mg/m2 po bid d1-14
• Q3w

References

Kang Y et al. Randomized phase III trial of capecitabine/cisplatin (XP) vs. continous infusion of 5-FU/cisplatin (FP) as first-line therapy in patients (pts) with advanced gastric cancer (AGC): efficacy and safety results. 2006 ASCO Annual Meeting. Abstract LBA4018